U.S.-China trade deal cuts tariffs for Beijing promise of big farm purchases

U.S.-China trade deal cuts tariffs for Beijing promise of big farm purchases
WASHINGTON/BEIJING (Reuters) – The United States and China cooled their trade war on Friday, announcing a “Phase one” agreement that reduces some U.S. tariffs in exchange for what U.S. officials said would be a big jump in Chinese purchases of American farm products and other goods. Beijing has agreed to import at least $200 billion in additional U.S. goods and... Read More

U.S.-China trade deal swaps tariff rollbacks for farm, energy purchases

U.S.-China trade deal swaps tariff rollbacks for farm, energy purchases
WASHINGTON/BEIJING (Reuters) – The United States and China cooled their trade war on Friday, announcing a “Phase one” agreement that reduces some U.S. tariffs in exchange for increased Chinese purchases of American farm products and other goods. Beijing has agreed to buy $32 billion in additional agricultural goods over the next two years, U.S. officials said, from a baseline of... Read More

Factbox: What’s in the U.S.-China ‘phase one’ trade deal

Factbox: What’s in the U.S.-China ‘phase one’ trade deal
WASHINGTON (Reuters) – The United States and China have agreed on the terms of a “phase one” trade deal that reduces some U.S. tariffs on Chinese goods while boosting Chinese purchases of American farm, energy and manufactured goods and addressing some U.S. complaints about intellectual property practices. Following are details of the deal released by both sides. The broad... Read More

Bristol-Myers wins $752 million in U.S. patent case against Gilead

Bristol-Myers wins $752 million in U.S. patent case against Gilead
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau (Reuters) – Bristol-Myers Squibb Co (BMY.N) on Friday said it won a $752 million jury verdict against Gilead Sciences Inc (GILD.O) in a U.S. patent dispute relating to technology for treating cancer.... Read More

Exclusive: Hudson’s Bay Co’s take-private deal falls short in shareholder vote – sources

Exclusive: Hudson’s Bay Co’s take-private deal falls short in shareholder vote – sources
(Reuters) – Saks Fifth Avenue owner Hudson’s Bay Co (HBC.TO) has fallen short of securing enough shareholder support for a C$1.9 billion($1.4 billion) deal to take the department store operator private, people familiar with the matter said on Friday. FILE PHOTO: A pedestrian walks past a Hudson’s Bay company sign at the retailer’s flagship Toronto store October 28, 2005. REUTERS/J.P.... Read More

Boeing bows out of multibillion-dollar Minuteman missile replacement competition

Boeing bows out of multibillion-dollar Minuteman missile replacement competition
FILE PHOTO: The Boeing logo is displayed on a screen, at the New York Stock Exchange (NYSE) in New York, U.S., August 7, 2019. REUTERS/Brendan McDermid WASHINGTON (Reuters) – Boeing Co (BA.N) has decided not to compete as a prime contractor to replace the Pentagon’s aging U.S.-based Minuteman III missile system, paving the way for Northrop Grumman Corp (NOC.N) to... Read More

Sanctions-hit refiner Nynas handed administrator by Swedish court

Sanctions-hit refiner Nynas handed administrator by Swedish court
STOCKHOLM (Reuters) – Nynas AB, owned by Venezuela’s state-run PDVSA and Finland’s Neste Oil (NESTE.HE), on Friday filed for company reorganization at a Swedish court as the refiner failed to extend loans as it dealt with the fallout of U.S. sanctions. Swedish Nynas’ business has suffered as the United States in October introduced changes to a license that had allowed... Read More